BRCA1 and cancer: Interestingly, TCGA data analysis on cancers that were not treated with PARPi suggests that a decrease in TLK kinases predicts poor outcome in BRCA1 deficient tumors, while it often predicts the opposite in BRCA1 proficient cancers.